Nevala-Plagemann C, Powers P, Mir-Kasimov M, Rose R
Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Department of Pulmonary Medicine and Critical Care, University of Utah, Salt Lake City, UT, USA.
Case Rep Med. 2019 Dec 27;2019:3136493. doi: 10.1155/2019/3136493. eCollection 2019.
Transfusion of blood products is a frequent and often necessary lifesaving intervention. While changes to blood bank practices over the past several decades have reduced the infectious complications associated with transfusions, risks still exist. Septic transfusion reactions caused by bacterial contamination of blood products, especially platelets, still occur relatively frequently. Unfortunately, clinical recognition of septic transfusion reactions is difficult due to significant symptom, exam, and laboratory abnormality overlap between different types of transfusion reactions, as well as other conditions. Novel methods have been developed to detect blood product contamination but have yet to be widely implemented in the United States.
A 67-year-old male with chronic thrombocytopenia was transfused with platelets prior to a planned procedure. Shortly afterwards, he developed fever and hypotension. He was transferred to the intensive care unit where he was treated with aggressive fluid resuscitation and broad-spectrum antibiotics. The patient went on to develop progressively worsening shock and profound disseminated intravascular coagulation. Blood cultures from the patient and the transfused platelets grew an species. Despite aggressive resuscitative efforts and appropriate antibiotics, the patient died approximately 48 hours following the transfusion reaction.
We report a fatal case of septic shock associated with bacteremia caused by platelet transfusion. Our review of the literature revealed only one other documented platelet transfusion associated fatality caused by species. Novel pathogen reduction and contamination detection methods have been developed but have yet to be widely adopted in the United States.
血液制品的输注是一种常见且往往必要的挽救生命的干预措施。尽管过去几十年血库操作的改变减少了与输血相关的感染并发症,但风险仍然存在。由血液制品,尤其是血小板的细菌污染引起的败血症性输血反应仍相对频繁发生。不幸的是,由于不同类型输血反应以及其他病症之间在症状、检查和实验室异常方面存在显著重叠,败血症性输血反应的临床识别较为困难。已开发出检测血液制品污染的新方法,但在美国尚未广泛应用。
一名67岁的慢性血小板减少男性在计划手术前输注了血小板。不久后,他出现发热和低血压。他被转入重症监护病房,在那里接受了积极的液体复苏和广谱抗生素治疗。患者随后出现进行性加重的休克和严重的弥散性血管内凝血。患者和输注血小板的血培养均培养出一种[细菌名称未给出]。尽管进行了积极的复苏努力并使用了适当的抗生素,但患者在输血反应后约48小时死亡。
我们报告了一例与血小板输注引起的[细菌名称未给出]菌血症相关的致命性败血症性休克病例。我们对文献的回顾显示,仅有另一例记录在案的由[细菌名称未给出]引起的与血小板输注相关的死亡病例。已开发出新的病原体灭活和污染检测方法,但在美国尚未广泛采用。